South San Francisco, CA, United States of America

Parbir Grewal

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Parbir Grewal: Innovator in Protein Formulations

Introduction

Parbir Grewal is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of protein formulations, particularly in developing methods to reduce oxidation in proteins. With a total of 2 patents, his work has implications for various industries, including pharmaceuticals and biotechnology.

Latest Patents

Grewal's latest patents focus on formulations that comprise a protein in combination with a compound that prevents oxidation of the protein. These inventions not only provide methods for creating such formulations but also outline methods of using them effectively. Furthermore, his patents include innovative approaches for screening compounds that can prevent oxidation in protein compositions, enhancing the stability and efficacy of protein-based products.

Career Highlights

Throughout his career, Parbir Grewal has worked with prominent companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these leading organizations has allowed him to refine his expertise in protein chemistry and formulation science.

Collaborations

Grewal has collaborated with several professionals in his field, including Sreedhara Alavattam and Mary Mallaney. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Parbir Grewal's innovative work in protein formulations demonstrates his commitment to enhancing the stability of proteins through advanced methods. His contributions are valuable to the scientific community and have the potential to impact various applications in biotechnology and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…